These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37640101)

  • 21. Skin sensitisation--moving forward with non-animal testing strategies for regulatory purposes in the EU.
    Basketter D; Alépée N; Casati S; Crozier J; Eigler D; Griem P; Hubesch B; de Knecht J; Landsiedel R; Louekari K; Manou I; Maxwell G; Mehling A; Netzeva T; Petry T; Rossi LH
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):531-5. PubMed ID: 24140884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory landscape of alternatives to animal testing in food safety evaluations with a focus on the western world.
    Reddy N; Lynch B; Gujral J; Karnik K
    Regul Toxicol Pharmacol; 2023 Sep; 143():105470. PubMed ID: 37591329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing the 3Rs in regulatory toxicology - Carcinogenicity testing: Scope for harmonisation and advancing the 3Rs in regulated sectors of the European Union.
    Annys E; Billington R; Clayton R; Bremm KD; Graziano M; McKelvie J; Ragan I; Schwarz M; van der Laan JW; Wood C; Öberg M; Wester P; Woodward KN
    Regul Toxicol Pharmacol; 2014 Jul; 69(2):234-42. PubMed ID: 24768934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-animal approaches for consumer safety risk assessments: Unilever's scientific research programme.
    Carmichael P; Davies M; Dent M; Fentem J; Fletcher S; Gilmour N; MacKay C; Maxwell G; Merolla L; Pease C; Reynolds F; Westmoreland C
    Altern Lab Anim; 2009 Dec; 37(6):595-610. PubMed ID: 20104996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
    Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
    ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
    Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
    Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting the future: opportunities and challenges for the chemical industry to apply 21st-century toxicity testing.
    Settivari RS; Ball N; Murphy L; Rasoulpour R; Boverhof DR; Carney EW
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):214-23. PubMed ID: 25836969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The vaccines consistency approach project: an EPAA initiative.
    De Mattia F; Hendriksen C; Buchheit KH; Chapsal JM; Halder M; Lambrigts D; Redhead K; Rommel E; Scharton-Kersten T; Sesardic T; Viviani L; Ragan I
    Pharmeur Bio Sci Notes; 2015; 2015():30-56. PubMed ID: 26830158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
    Konishi Y; Hayashi SM; Fukushima S
    Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards an animal-free human health assessment: starting from the current regulatory needs.
    Bos PMJ; Geraets L; De Wit-Bos L; Heringa M; Van Engelen J
    ALTEX; 2020; 37(3):395-408. PubMed ID: 32113186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upholding the EU's Commitment to 'Animal Testing as a Last Resort' Under REACH Requires a Paradigm Shift in How We Assess Chemical Safety to Close the Gap Between Regulatory Testing and Modern Safety Science.
    Fentem J; Malcomber I; Maxwell G; Westmoreland C
    Altern Lab Anim; 2021 Jul; 49(4):122-132. PubMed ID: 34461762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell-derived systems in toxicology assessment.
    Suter-Dick L; Alves PM; Blaauboer BJ; Bremm KD; Brito C; Coecke S; Flick B; Fowler P; Hescheler J; Ingelman-Sundberg M; Jennings P; Kelm JM; Manou I; Mistry P; Moretto A; Roth A; Stedman D; van de Water B; Beilmann M
    Stem Cells Dev; 2015 Jun; 24(11):1284-96. PubMed ID: 25675366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concept of REACH and impact on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jan; 27(1):5-21. PubMed ID: 18480145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation.
    Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K
    Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment.
    Vogel R; Seidle T; Spielmann H
    Reprod Toxicol; 2010 Apr; 29(2):242-5. PubMed ID: 19808091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.